Biotechnology Value Fund's Ownership in Invivyd, Inc.

Biotechnology Value Fund, L.P. and related entities have filed a Schedule 13G disclosing their ownership in Invivyd, Inc. As of October 22, 2025, the entities collectively own approximately 7.4% of Invivyd's common stock. The filing includes Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS LP, and their respective general partners and affiliates. Mark N. Lampert, as a director and officer of BVF Inc., is also deemed to beneficially own these shares. The filing indicates that the shares were not acquired for the purpose of influencing the control of the issuer.